Brokerages Set Capricor Therapeutics Inc (NASDAQ:CAPR) PT at $34.50
Shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) have received a consensus rating of “Buy” from the six brokerages that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have issued ratings on the stock in […]
Shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Get Free Report) have received a consensus rating of “Buy” from the six brokerages that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have issued ratings on the stock in […]